As per the recent report by FMI, global sales of the pelvic floor stimulators industry are projected to total US$ 140.39 million for 2023. The demand outlook for the market remains buoyant as FMI forecasts it to exhibit a CAGR of 8.8% from 2023 to 2033, reaching US$ 325.41 million by 2033.
The market growth in being induced by the following factors:
| Attribute | Details |
|---|---|
| Pelvic Floor Stimulators Market Size (2023) | US$ 140.39 million |
| Pelvic Floor Stimulators Market Size (2033) | US$ 325.41 million |
| Pelvic Floor Stimulators Forecast CAGR (2023 to 2033) | 8.8% |
| Pelvic Floor Stimulators Market Size (2022) | US$ 129.04 million |
| Pelvic Floor Stimulators Historical CAGR (2018 to 2022) | 4.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Adopting telehealth facilities for pelvic floor care is expected to create attractive opportunities for manufacturers. The advent of telemedicine has improved access to care, enhanced resource productivity, and reduced costs related to traditional office visits in a wide array of medical fields.
Top healthcare institutes are adopting telehealth for patients' convenience to discuss pelvic floor dysfunction problems and other related disorders. With telehealth, HCPs could interact with patients sequestered in their homes. Hospitals like UCLA are now focusing on teleconsultation to reach people to provide support.
Despite urinary incontinence's social and financial burden, fewer than half of women with significant PFD symptoms pursue treatment. Besides this, women often feel personal embarrassment, unaware that PFDs are medical conditions and that treatment options exist. A lack of awareness is expected to continue restraining growth in the market.
Similarly, inadequate reimbursement policies in countries with poor economies are projected to hinder market growth. Insurance payers are reluctant to cover PFDs as the treatment mainly covers physical therapy. Some insurers consider physical therapy medically necessary with a provider referral.
Other insurers place a cap on visits they are going to cover per year. Affordability is a significant problem for a considerable chunk of the population due to the absence of health insurance and government support policies that cover treatment in developing countries such as India and China. This absence of social health insurance and the exclusionary provision of private health insurance schemes significantly limit the pelvic floor stimulators industry.
Principal Consultant
FMI predicts the pelvic floor stimulator sales to record a surge at 8.8% CAGR between 2023 and 2033 as against sales growth of 4.8% registered in 2018 to 2022. Demand is projected to continue rising in response to the surging cases of urinary incontinence around the world.
According to sources from the National Association for Continence (NAFC), around 200 million adults are suffering from some form of urinary incontinence worldwide. It further states that the condition is more common in women and says that the United States accounts for 25 million adult patients, up to 80% being women.
Similarly, the growing incidence of diabetes and hypertension is a significant factor in the increase of patients suffering from urinary incontinence. This, in turn, is driving the demand for pelvic floor stimulators. FMI has predicted the demand for female stress urinary incontinence treatment devices to gain considerable momentum in the near future. This is projected to, in turn, present opportunities for pelvic floor stimulator market players to capitalize on.
According to a report published by the World Health Organization (WHO) in 2019, about 1.13 billion people have hypertension. Diabetes is the leading cause of advanced renal failure, followed by hypertension, which affects about one billion people worldwide.
Pelvic floor stimulators are often administered to offer advanced care to patients suffering from end-stage renal diseases. FMI sees this as a chief growth driver of the market. Coupled with this, technological advancements reported in the healthcare sector, besides the rising emphasis on non-invasive treatments, are projected to pave the way for the expansion of the market in the coming years.
Non-invasive treatments also stimulate muscle pathways and nerves without requiring active patient involvement, which is expected to drive the demand during the forecast period.
New products are being integrated with Bluetooth to connect with smartphones for real-time progress tracking without the risks of surgery or adverse effects associated with treatment. In February 2020, Atlantic Therapeutics (Ireland) received clearance from the FDA, allowing the wearable electric muscle stimulator device to be sold over the counter for treating stress urinary incontinence.
These developments are projected to remain crucial for the market, enabling pelvic floor stimulator manufacturers to up their game in the coming years.
The United States holds over 76% share of the North America pelvic floor stimulators industry. As per the Department of Health and Human Services of the United States, urinary incontinence is observed to be twice as common among women when compared with men.
This can be attributed to childbirth, pregnancy, and menopause. Urinary incontinence is not a normal part of aging and can be treated. Over the last decade, electrical stimulation has developed as one of the most advanced and unique types of biofeedback that can be used for pelvic floor muscle rehabilitation in the United States.
The growing inclination toward research and development is to find a cost-effective and efficient pelvic floor exercise method. Moreover, the rising focus on first-line conservative management programs for women suffering from urinary incontinence is a significant factor likely to fuel the adoption of pelvic floor stimulators in the United States.
| Country | The United Kingdom |
|---|---|
| Forecast CAGR (2023 to 2033) | 8.7% |
The United Kingdom accounts for over 25% share of the Europe market through the assessment period ending in 2033. The high prevalence of urinary incontinence, the surge in the adoption of technologically advanced products, a large base of medical device companies, and a massive pipeline of products drive demand.
The market in the United Kingdom is likely to expand at a high CAGR of 8.7% during the forecast period. Around 6 million people in the United Kingdom are suffering from urinary incontinence, according to the National Health Service (2017).
The Indian market accounts for more than 55% of the sales registered in South Asia in 2022. Various factors, such as growing investment by leading players, increasing government spending, and awareness programs by several government and non-government organizations, are driving the market growth.
The Urological Society of India enlisted guidelines for increasing awareness about urinary incontinence in the country. Furthermore, increasing healthcare expenditure due to the pandemic has created a greater scope for adoption. The growing population makes it a promising market in the coming years.
| Country | Australia |
|---|---|
| Forecast CAGR (2023 to 2033) | 10.6% |
The market for pelvic floor stimulators in Australia is exhibiting a 10.6% CAGR and is projected to account for more than 83% of the Oceania market throughout the projection period. Increasing government initiatives to create awareness is anticipated to boost regional market growth.
The Australian government has developed the Continence Aids Payment Scheme (CAPS) to support patients with severe incontinence problems with their needs. They have also launched National Continence Management Program to increase awareness about numerous bowel and bladder health problems.
Moreover, urologists, urogynecologists, gynecologists, nurses, and other skilled organizations have actively promoted awareness of urinary continence. The International Continence Society (ICS) has created the Continence Promotion Committee (CPC) to encourage public awareness programs, education, and services, about urinary incontinence globally. Thus, a growth in awareness programs regarding pelvic floor diseases and the increasing incidence of urinary incontinence (UI) by different government and non-profit organizations are fueling the pelvic floor stimulator industry.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Electrical Stimulators |
|---|---|
| Forecast CAGR (2023 to 2033) | 9.1% |
Electrical stimulators have a higher potential for growth in the coming years. The segment is likely to expand with a high CAGR of 9.1% in the coming decade. Electrical stimulation has appeared as one of the advanced and unique biofeedback types used for pelvic floor muscle rehabilitation.
The growing inclination to find a cost-effective and efficient pelvic floor exercise method with a rising focus on first-line conservative management programs for urinary incontinence in women is likely to fuel the adoption of electrical stimulators.
The urinary incontinence segment is expected to contribute maximum revenue share in the global pelvic floor stimulators market. In terms of revenue, the urinary incontinence segment accounted for over 76% share in 2022.
Urinary incontinence is considered a significant health problem globally. It has a considerable economic and social impact on individuals and society. The rapid expansion of the geriatric population base is among the primary aspects leading to the increase in pelvic floor disorders.
As per estimates by the UNU (United Nations University), the percentage of the geriatric population above 65 is expected to rise to 16% by 2050 from 7% in 2000. Thus, the rising prevalence of urinary incontinence among elderly women in several regions has significantly driven the demand for pelvic floor stimulators.
| Segment | Hospitals |
|---|---|
| Forecast CAGR (2023 to 2033) | 9.2% |
Hospitals are leading the market, with significant growth in the pelvic floor stimulators industry, with a 9.2% CAGR in the forecast period. Similarly, hospitals can impact higher investment abilities and capital with improved admittance to cutting-edge technologies and patient care, projected to enhance the market growth in the long term.
Manufacturers in the pelvic floor stimulators market are primarily aiming to carry out strategic collaborations while investing in research and development to consolidate growth in a competitive and fragmented market. Key players are also expanding their global and regional presence through product launches, acquisitions, expansions, and upgrading distribution channels to penetrate the pelvic floor stimulators industry.
| Attribute | Details |
|---|---|
| Pelvic Floor Stimulators Market Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Pelvic Floor Stimulators Industry Analysis | US$ million for Value in million |
| Key Countries Covered | The United States, Canada, the United Kingdom, Germany, Italy, France, Spain, Benelux, Russia, India, Thailand, Malaysia, Indonesia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, South Africa and North Africa |
| Key Segments Covered | Product Type, Application, End User, and Region |
| Pelvic Floor Stimulators Market - Key Companies Profiled | Medtronic Plc; Atlantic Therapeutics; Laborie Inc.; The Prometheus Group; Everyway Medical Instruments Co.; Ltd.; KayCo 2 Ltd.; InControl Medical Ltd.; Tic Medizintechnik GmbH; Shenzhen XFT Medical Ltd.; Chiaro Technology Ltd.; Zynex Inc.; Utah Medical Products; Inc.; Verity Medical Ltd. |
| Pelvic Floor Stimulators Market - Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market boosted at a CAGR of 4.8% from 2018 to 2022.
Through 2033, the market is to develop at a CAGR of 8.8%.
By 2033, the market is to have expanded to US$ 325.41 million.
In 2023, the market is anticipated to reach a worth of US$ 140.39 million.
The United States controls 76% of the North American market.
The Indian market accounts for more than 55% of all South Asian sales.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Electrical Stimulators 5.3.2. Magnetic Stimulators 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Urinary Incontinence 6.3.2. Sexual Dysfunction 6.3.3. Neurodegenerative Diseases 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis by End-User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End-User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Specialized clinics 7.3.4. Homecare setting 7.4. Y-o-Y Growth Trend Analysis by End-User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis by End-User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East & Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End-User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End-User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End-User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. United Kingdom 11.2.1.2. Germany 11.2.1.3. France 11.2.1.4. Italy 11.2.1.5. Spain 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End-User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Russia 12.2.1.2. Poland 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End-User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End-User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By End-User 14.4. Key Takeaways 15. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Iran 15.2.1.2. Turkey 15.2.1.3. Rest of MEA 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By End-User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End-User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By End-User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By End-User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By End-User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By End-User 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By End-User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By End-User 16.7. Germany 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By End-User 16.8. France 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By End-User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By End-User 16.10. Spain 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By End-User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By End-User 16.12. Poland 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By End-User 16.13. Czech Republic 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By End-User 16.14. Romania 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By End-User 16.15. India 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By End-User 16.16. Bangladesh 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By End-User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By End-User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By End-User 16.19. China 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By End-User 16.20. Japan 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By End-User 16.21. South Korea 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Application 16.21.2.3. By End-User 16.22. Iran 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Application 16.22.2.3. By End-User 16.23. Turkey 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Application 16.23.2.3. By End-User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By End-User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Medtronic Plc 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Atlantic Therapeutics 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Laborie Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. The Prometheus Group 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Everyway Medical Instruments Co., Ltd. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. KayCo 2 Ltd. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. InControl Medical Ltd. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Tic Medizintechnik GmbH 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Shenzhen XFT Medical Ltd. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Chiaro Technology Ltd. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Zynex Inc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Utah Medical Products, Inc. 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Verity Medical Ltd. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Pelvic Floor Stimulators Market
